<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Five_ATP12A_Tactics_Revealed</id>
		<title>Five ATP12A Tactics Revealed - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Five_ATP12A_Tactics_Revealed"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Five_ATP12A_Tactics_Revealed&amp;action=history"/>
		<updated>2026-04-20T20:48:42Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=Five_ATP12A_Tactics_Revealed&amp;diff=45304&amp;oldid=prev</id>
		<title>Brianoffice0 : Page créée avec « The Abs used were anti-ERK1/2 Ab, anti-phospho-ERK1/2 Ab, anti-phospho-JNK Ab, anti-phospho-p38MAPK Ab, anti-phospho-MSK1 Ab (Cell Signaling Technology, Danvers, MA, USA),... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Five_ATP12A_Tactics_Revealed&amp;diff=45304&amp;oldid=prev"/>
				<updated>2016-12-06T06:48:47Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « The Abs used were anti-ERK1/2 Ab, anti-phospho-ERK1/2 Ab, anti-phospho-JNK Ab, anti-phospho-p38MAPK Ab, anti-phospho-MSK1 Ab (Cell Signaling Technology, Danvers, MA, USA),... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The Abs used were anti-ERK1/2 Ab, anti-phospho-ERK1/2 Ab, anti-phospho-JNK Ab, anti-phospho-p38MAPK Ab, anti-phospho-MSK1 Ab (Cell Signaling Technology, Danvers, MA, USA), and anti-MSK1 Ab (Santa Cruz Biotechnology, Santa Cruz, CA). A panel of kinase protein controls was included and run in parallel. Two controls included phosphorylated JNK and p38MAPK control cellular extracts (Cell Signaling Technology). For analysis [http://www.selleckchem.com/products/ozanimod-rpc1063.html click here] of involvement of the ERK1/2-MSK1 pathway, BEAS-2B cells were treated in the presence or absence of the following kinase inhibitors at varying doses: MEK1/2 inhibitor, PD98059; p38MAPK inhibitor, SB202190; JNK inhibitor, SP600125; MSK1 inhibitors, H89 and Ro-31-8220 (Calbiochem, San Diego, CA); and a vehicle control, 0.1%DMSO for 1�h before treatment with IL-33 (100�ng/ml). The supernatants were harvested at 24�h after stimulation for analyses with ELISA. IL-17F protein levels in the supernatants were determined as described above. These values are expressed as mean���SD (n?? experiments). Predesigned siRNAs for MSK1 (Santa Cruz Biotechnology) and control siRNAs (Ambion, Tokyo, Japan) were used. The siRNA transfection into BEAS-2B cells was performed according to the manufacturer's instruction. The supernatants were then harvested at 24�h after stimulation with 100�ng/ml of IL-33 and subjected to analysis by ELISA, respectively (each n?? experiments). IL-17F protein [http://en.wikipedia.org/wiki/ATP12A ATP12A] levels in the supernatants are expressed as mean���SD. The statistical significance of differences was determined [http://www.selleckchem.com/products/azd3759.html find more] by analysis of variance (anova). The values are expressed as mean���SD from independent experiments. Any difference with P values&lt;/div&gt;</summary>
		<author><name>Brianoffice0</name></author>	</entry>

	</feed>